Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference

SAN DIEGO, Nov. 5 Neurocrine Biosciences, Inc.(Nasdaq: NBIX) announced today that Neurocrine Biosciences will present at theCIBC World Markets 18th Annual Healthcare Conference. The live presentationwill take place Tuesday, November 6, 2007 at 8:00 a.m. Eastern Time (ET)/5:00a.m. Pacific Time (PT). The presentation will be simultaneously webcast andmay be accessed on the Company's website at http://www.neurocrine.com

If you are unable to attend the webcast and would like further informationon this announcement please contact the Investor Relations Department atNeurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit thewebsite approximately 5 minutes prior to the presentation to download orinstall any necessary software. A replay of the presentation will be archivedon the website for two weeks.

About Neurocrine

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical Companyfocused on neurological and endocrine diseases and disorders. Our productcandidates address some of the largest pharmaceutical markets in the worldincluding insomnia, anxiety, depression, endometriosis, pain, irritable bowelsyndrome, and autoimmunity. Neurocrine Biosciences, Inc. news releases areavailable through the Company's website via the Internet athttp://www.neurocrine.com.

SOURCE Neurocrine Biosciences, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...